NL-OMON27672尚未招募不适用
Adjusting infliximab dose in IBD patients in remission, based on infliximab trough levels: the study on Infliximab Levels in IBD patients Steering Treatment, the ILIST pilot
Erasmus MC Rotterdam0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age 18-70
- •2. Written informed consent
排除标准
- •1. Concomitant corticosteroid usage
- •2. Pregnancy or lactation
研究者
相似试验
进行中（未招募）
1 期
Adjusting the amount of medication (infliximab) in patients suffering from inflammatory bowel disease, using medication levels in blood.Crohns diseaseUlcerative colitisMedDRA version: 19.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 19.0Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2013-002651-15-NLZon MW
招募中
不适用
owering infliximab dose in IBD patients in remission, based on infliximab trough levels: the study on Lowering Infliximab in IBD patients in sustained Remission, the LIR study10017969Inflammatory Bowel DiseaseNL-OMON44819Erasmus MC, Universitair Medisch Centrum Rotterdam110
招募中
不适用
Increasing time between adalimumab injections in IBD patients.Crohn's DiseaseUlcerative ColitisInflammatory Bowel DiseaseAdalimumabNL-OMON20310Erasmus MC72
尚未招募
4 期
engthening Adalimumab Dosing Interval in IBD patients in long term remission, the LADI study.Inflammatory bowel disease10017969NL-OMON40962Erasmus MC, Universitair Medisch Centrum Rotterdam80
进行中（未招募）
不适用
Increasing the time between adalimumab injections from two to threeweeks, in patients with inflammatory bowel disease.Inflammatory bowel diseaseEUCTR2014-001919-39-NLErasmus MC